Lipocine Inc (LPCN)

[BesaoT35]

Thanks Millstone. Great article. If things go well for LPCN in the Clarus jury trial or they settle before the trial, then LPCN could see revenues or a deal happen sooner than March 2022.

NASH also looks like the trials might show that TRT does indeed work for nonalcoholic fatty liver disease. Those are two shots on goal. The once a day TRT oral pill would just be icing on the cake.

I sound like a pumper. I do realize that dilution is always a risk on the horizon.